Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.140
-0.100 (-8.06%)
At close: Mar 28, 2025, 4:00 PM
1.130
-0.010 (-0.88%)
After-hours: Mar 28, 2025, 7:59 PM EDT

PACB Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
154.01200.52128.3130.5178.89
Upgrade
Revenue Growth (YoY)
-23.19%56.29%-1.69%65.43%-13.20%
Upgrade
Cost of Revenue
106.34142.3274.8371.3546.33
Upgrade
Gross Profit
47.6758.253.4759.1732.57
Upgrade
Selling, General & Admin
175.02169.82160.85124.1272.8
Upgrade
Research & Development
134.92187.17193112.964.15
Upgrade
Other Operating Expenses
13.443.71--
Upgrade
Operating Expenses
338.34368.56358.29237.33136.95
Upgrade
Operating Income
-290.66-310.37-304.82-178.16-104.39
Upgrade
Interest Expense
-13.41-14.34-14.69-12.53-0.27
Upgrade
Other Non Operating Income (Expenses)
10.7419.847.394.11.95
Upgrade
EBT Excluding Unusual Items
-293.34-304.86-312.12-186.59-102.7
Upgrade
Merger & Restructuring Charges
--9.04--83.1334
Upgrade
Impairment of Goodwill
-144.5----
Upgrade
Gain (Loss) on Sale of Investments
13.0412.840.24-4.010.11
Upgrade
Asset Writedown
-40----
Upgrade
Other Unusual Items
155.26-17.09-2.38-1.1498
Upgrade
Pretax Income
-309.54-318.16-314.25-274.8729.4
Upgrade
Income Tax Expense
0.32-11.42--93.65-
Upgrade
Net Income
-309.85-306.74-314.25-181.2229.4
Upgrade
Net Income to Common
-309.85-306.74-314.25-181.2229.4
Upgrade
Shares Outstanding (Basic)
274254225204165
Upgrade
Shares Outstanding (Diluted)
274254225204175
Upgrade
Shares Change (YoY)
8.22%12.95%10.00%16.67%14.71%
Upgrade
EPS (Basic)
-1.13-1.21-1.40-0.890.18
Upgrade
EPS (Diluted)
-1.13-1.21-1.40-0.890.17
Upgrade
Free Cash Flow
-212.25-268.02-279.96-117.1118.46
Upgrade
Free Cash Flow Per Share
-0.77-1.06-1.25-0.570.11
Upgrade
Gross Margin
30.95%29.02%41.68%45.33%41.28%
Upgrade
Operating Margin
-188.73%-154.78%-237.58%-136.51%-132.31%
Upgrade
Profit Margin
-201.18%-152.97%-244.93%-138.85%37.27%
Upgrade
Free Cash Flow Margin
-137.81%-133.66%-218.20%-89.73%23.40%
Upgrade
EBITDA
-249.48-290.64-294.43-170.58-97.96
Upgrade
EBITDA Margin
-161.98%-144.94%-229.47%-130.70%-124.16%
Upgrade
D&A For EBITDA
41.1919.7210.397.586.43
Upgrade
EBIT
-290.66-310.37-304.82-178.16-104.39
Upgrade
EBIT Margin
-188.73%-154.78%-237.58%-136.51%-132.31%
Upgrade
Revenue as Reported
154.01200.52128.3130.5178.89
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q